SODIUM CHANNEL-BLOCKING AGENTS - THEIR USE IN NEUROPATHIC PAIN CONDITIONS

被引:0
|
作者
TANELIAN, DL [1 ]
VICTORY, RA [1 ]
机构
[1] UNIV TEXAS,SW MED CTR,DEPT ANESTHESIOL & PAIN MANAGEMENT,PAIN RES PROGRAM,DALLAS,TX 75235
来源
PAIN FORUM | 1995年 / 4卷 / 02期
关键词
NEUROPATHIC PAIN; CHRONIC PAIN; MEXILETINE; CARBAMAZEPINE; PHENYTOIN; LOCAL ANESTHETICS; LIDOCAINE; PROCAINE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain conditions are due to damage or permanent alteration of the peripheral or central nervous system. These conditions are generally chronic and less responsive to opiates than nociceptive (acute) pain conditions; as such, they are very difficult to treat clinically. Numerous classes of drugs, including opiates, antidepressants, anticonvulsants, local anesthetics, antiarrhythmics, steroids, antipsychotic agents, and topical capsaicin have been used to treat neuropathic pain. One mechanism common to several of these pharmacological agents is their ability to block sodium channels in a use-dependent fashion. In this focus article clinical evidence of the effectiveness of sodium channel-blocking drugs for relieving neuropathic pain will be presented. Experimental evidence for the site of action of these drugs will be discussed, along with future studies that are needed to develop new, more effective, agents.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [1] Antinociceptive effects of sodium channel-blocking agents on acute pain in mice
    Sakaue, A
    Honda, M
    Tanabe, M
    Ono, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) : 181 - 188
  • [2] Sodium channel-blocking agents are not of benefit to rats with kaolin-induced hydrocephalus
    Del Bigio, MR
    Wang, X
    Wilson, MJ
    NEUROSURGERY, 2002, 51 (02) : 460 - 466
  • [3] Sodium channel-blocking agents are not of benefit to rats with kaolin-induced hydrocephalus - Comments
    Milhorat, TH
    Ellenbogen, RG
    McComb, JG
    Drake, JM
    NEUROSURGERY, 2002, 51 (02) : 466 - 467
  • [4] ANTIARRHYTHMIC AGENTS - THE MODULATED RECEPTOR MECHANISM OF ACTION OF SODIUM AND CALCIUM CHANNEL-BLOCKING DRUGS
    HONDEGHEM, LM
    KATZUNG, BG
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1984, 24 : 387 - 423
  • [5] Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction?
    Novy, Jan
    Patsalos, Philip N.
    Sander, Josemir W.
    Sisodiya, Sanjay M.
    EPILEPSY & BEHAVIOR, 2011, 20 (01) : 20 - 23
  • [6] Blocking sodium channels to treat neuropathic pain
    Priest, Birgit T.
    Kaczorowski, Gregory J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (03) : 291 - 306
  • [7] CALCIUM CHANNEL-BLOCKING DRUGS
    MILLERHANCE, WC
    STULL, JT
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (12): : 1216 - 1216
  • [9] Sodium channel subtypes and neuropathic pain
    Chung, JM
    Dib-Hajj, SD
    Lawson, SN
    PROCEEDINGS OF THE 10TH WORLD CONGRESS ON PAIN, 2003, 24 : 99 - 114
  • [10] Sodium channel blockers for neuropathic pain
    Zuliani, Valentina
    Rivara, Mirko
    Fantini, Marco
    Costantino, Gabriele
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (06) : 755 - 779